世界の顆粒球コロニー刺激因子（G-CSF）薬剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5760
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、117ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、顆粒球コロニー刺激因子（G-CSF）薬剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（フィルグラスチム、ペフィグラスチム、リペフィグラスチム）、用途別市場規模（腫瘍学、造血系疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・顆粒球コロニー刺激因子（G-CSF）薬剤の市場動向
・企業の競争状況、市場シェア
・顆粒球コロニー刺激因子（G-CSF）薬剤の種類別市場規模と予測2016-2027（フィルグラスチム、ペフィグラスチム、リペフィグラスチム）
・顆粒球コロニー刺激因子（G-CSF）薬剤の用途別市場規模と予測2016-2027（腫瘍学、造血系疾患、その他）
・顆粒球コロニー刺激因子（G-CSF）薬剤の北米市場規模2016-2027（アメリカ、カナダ）
・顆粒球コロニー刺激因子（G-CSF）薬剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・顆粒球コロニー刺激因子（G-CSF）薬剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・顆粒球コロニー刺激因子（G-CSF）薬剤の中南米市場規模2016-2027（メキシコ、ブラジル）
・顆粒球コロニー刺激因子（G-CSF）薬剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Amgen、Kyowa Kirin、Chugai Pharmaceutical、Novartis、Teva、Pfizer、Merck、Dong-A Socio、Intas、GenSci、Dr. Reddy、Amoytop、North China Pharmaceutical、SL Pharm、Hayao Group）
・結論

Granulocyte colony-stimulating factor (G-CSF or GCSF), also known as colony-stimulating factor 3 (CSF 3), is a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cells and release them into the bloodstream.

Market Analysis and Insights: Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market
The global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market.

Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Scope and Market Size
Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Filgrastim
Pefigrastim
Lipefigrastim

Segment by Application
Oncology
Blood Disease
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amgen
Kyowa Kirin
Chugai Pharmaceutical
Novartis
Teva
Pfizer
Merck
Dong-A Socio
Intas
GenSci
Dr. Reddy
Amoytop
North China Pharmaceutical
SL Pharm
Hayao Group

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Filgrastim
1.2.3 Pefigrastim
1.2.4 Lipefigrastim
1.3 Market by Application
1.3.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oncology
1.3.3 Blood Disease
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Perspective (2016-2027)
2.2 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Growth Trends by Regions
2.2.1 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Industry Dynamic
2.3.1 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Trends
2.3.2 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Drivers
2.3.3 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Challenges
2.3.4 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Players by Revenue
3.1.1 Global Top Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Players by Revenue (2016-2021)
3.1.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue
3.4 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Concentration Ratio
3.4.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue in 2020
3.5 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Key Players Head office and Area Served
3.6 Key Players Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Solution and Service
3.7 Date of Enter into Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Breakdown Data by Type
4.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Historic Market Size by Type (2016-2021)
4.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecasted Market Size by Type (2022-2027)

5 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Breakdown Data by Application
5.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Historic Market Size by Application (2016-2021)
5.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size (2016-2027)
6.2 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type
6.2.1 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021)
6.2.2 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2022-2027)
6.2.3 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2027)
6.3 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application
6.3.1 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021)
6.3.2 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2022-2027)
6.3.3 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2027)
6.4 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country
6.4.1 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2016-2021)
6.4.2 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size (2016-2027)
7.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type
7.2.1 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021)
7.2.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2022-2027)
7.2.3 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2027)
7.3 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application
7.3.1 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021)
7.3.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2022-2027)
7.3.3 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2027)
7.4 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country
7.4.1 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2016-2021)
7.4.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size (2016-2027)
8.2 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type
8.2.1 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application
8.3.1 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Region
8.4.1 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size (2016-2027)
9.2 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type
9.2.1 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2027)
9.3 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application
9.3.1 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2027)
9.4 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country
9.4.1 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size (2016-2027)
10.2 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type
10.2.1 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application
10.3.1 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country
10.4.1 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.1.4 Amgen Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Kyowa Kirin
11.2.1 Kyowa Kirin Company Details
11.2.2 Kyowa Kirin Business Overview
11.2.3 Kyowa Kirin Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.2.4 Kyowa Kirin Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.2.5 Kyowa Kirin Recent Development
11.3 Chugai Pharmaceutical
11.3.1 Chugai Pharmaceutical Company Details
11.3.2 Chugai Pharmaceutical Business Overview
11.3.3 Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.3.4 Chugai Pharmaceutical Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.3.5 Chugai Pharmaceutical Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.4.4 Novartis Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.5.4 Teva Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.5.5 Teva Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.6.4 Pfizer Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.7.4 Merck Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Dong-A Socio
11.8.1 Dong-A Socio Company Details
11.8.2 Dong-A Socio Business Overview
11.8.3 Dong-A Socio Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.8.4 Dong-A Socio Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.8.5 Dong-A Socio Recent Development
11.9 Intas
11.9.1 Intas Company Details
11.9.2 Intas Business Overview
11.9.3 Intas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.9.4 Intas Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.9.5 Intas Recent Development
11.10 GenSci
11.10.1 GenSci Company Details
11.10.2 GenSci Business Overview
11.10.3 GenSci Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.10.4 GenSci Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.10.5 GenSci Recent Development
11.11 Dr. Reddy
11.11.1 Dr. Reddy Company Details
11.11.2 Dr. Reddy Business Overview
11.11.3 Dr. Reddy Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.11.4 Dr. Reddy Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.11.5 Dr. Reddy Recent Development
11.12 Amoytop
11.12.1 Amoytop Company Details
11.12.2 Amoytop Business Overview
11.12.3 Amoytop Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.12.4 Amoytop Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.12.5 Amoytop Recent Development
11.13 North China Pharmaceutical
11.13.1 North China Pharmaceutical Company Details
11.13.2 North China Pharmaceutical Business Overview
11.13.3 North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.13.4 North China Pharmaceutical Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.13.5 North China Pharmaceutical Recent Development
11.14 SL Pharm
11.14.1 SL Pharm Company Details
11.14.2 SL Pharm Business Overview
11.14.3 SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.14.4 SL Pharm Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.14.5 SL Pharm Recent Development
11.15 Hayao Group
11.15.1 Hayao Group Company Details
11.15.2 Hayao Group Business Overview
11.15.3 Hayao Group Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.15.4 Hayao Group Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.15.5 Hayao Group Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Filgrastim
Table 3. Key Players of Pefigrastim
Table 4. Key Players of Lipefigrastim
Table 5. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Regions (2016-2021)
Table 9. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Regions (2022-2027)
Table 11. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Trends
Table 12. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Drivers
Table 13. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Challenges
Table 14. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Restraints
Table 15. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Players (2016-2021)
Table 17. Global Top Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs as of 2020)
Table 18. Ranking of Global Top Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Solution and Service
Table 22. Date of Enter into Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Amgen Company Details
Table 63. Amgen Business Overview
Table 64. Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 65. Amgen Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 66. Amgen Recent Development
Table 67. Kyowa Kirin Company Details
Table 68. Kyowa Kirin Business Overview
Table 69. Kyowa Kirin Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 70. Kyowa Kirin Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 71. Kyowa Kirin Recent Development
Table 72. Chugai Pharmaceutical Company Details
Table 73. Chugai Pharmaceutical Business Overview
Table 74. Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 75. Chugai Pharmaceutical Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 76. Chugai Pharmaceutical Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 80. Novartis Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. Teva Company Details
Table 83. Teva Business Overview
Table 84. Teva Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 85. Teva Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 86. Teva Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 90. Pfizer Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Merck Company Details
Table 93. Merck Business Overview
Table 94. Merck Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 95. Merck Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 96. Merck Recent Development
Table 97. Dong-A Socio Company Details
Table 98. Dong-A Socio Business Overview
Table 99. Dong-A Socio Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 100. Dong-A Socio Recent Development
Table 101. Intas Company Details
Table 102. Intas Business Overview
Table 103. Intas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 104. Intas Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 105. Intas Recent Development
Table 106. GenSci Company Details
Table 107. GenSci Business Overview
Table 108. GenSci Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 109. GenSci Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 110. GenSci Recent Development
Table 111. Dr. Reddy Company Details
Table 112. Dr. Reddy Business Overview
Table 113. Dr. Reddy Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 114. Dr. Reddy Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 115. Dr. Reddy Recent Development
Table 116. Amoytop Company Details
Table 117. Amoytop Business Overview
Table 118. Amoytop Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 119. Amoytop Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 120. Amoytop Recent Development
Table 121. North China Pharmaceutical Company Details
Table 122. North China Pharmaceutical Business Overview
Table 123. North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 124. North China Pharmaceutical Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 125. North China Pharmaceutical Recent Development
Table 126. SL Pharm Company Details
Table 127. SL Pharm Business Overview
Table 128. SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 129. SL Pharm Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 130. SL Pharm Recent Development
Table 131. Hayao Group Company Details
Table 132. Hayao Group Business Overview
Table 133. Hayao Group Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 134. Hayao Group Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 135. Hayao Group Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Type: 2020 VS 2027
Figure 2. Filgrastim Features
Figure 3. Pefigrastim Features
Figure 4. Lipefigrastim Features
Figure 5. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Application: 2020 VS 2027
Figure 6. Oncology Case Studies
Figure 7. Blood Disease Case Studies
Figure 8. Other Case Studies
Figure 9. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Report Years Considered
Figure 10. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Regions: 2020 VS 2027
Figure 13. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Regions (2022-2027)
Figure 14. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Players in 2020
Figure 15. Global Top Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue in 2020
Figure 17. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue Market Share by Type (2022-2027)
Figure 19. North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Type (2016-2027)
Figure 21. North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Application (2016-2027)
Figure 22. North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Country (2016-2027)
Figure 23. United States Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Type (2016-2027)
Figure 27. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Application (2016-2027)
Figure 28. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Country (2016-2027)
Figure 29. Germany Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Region (2016-2027)
Figure 39. China Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Type (2016-2027)
Figure 47. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Application (2016-2027)
Figure 48. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Country (2016-2027)
Figure 49. Mexico Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Country (2016-2027)
Figure 55. Turkey Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Amgen Revenue Growth Rate in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
Figure 59. Kyowa Kirin Revenue Growth Rate in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
Figure 60. Chugai Pharmaceutical Revenue Growth Rate in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
Figure 62. Teva Revenue Growth Rate in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
Figure 65. Dong-A Socio Revenue Growth Rate in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
Figure 66. Intas Revenue Growth Rate in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
Figure 67. GenSci Revenue Growth Rate in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
Figure 68. Dr. Reddy Revenue Growth Rate in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
Figure 69. Amoytop Revenue Growth Rate in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
Figure 70. North China Pharmaceutical Revenue Growth Rate in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
Figure 71. SL Pharm Revenue Growth Rate in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
Figure 72. Hayao Group Revenue Growth Rate in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

以下、関連資料のご紹介

顆粒球マクロファージコロニー刺激因子のグローバル市場調査 2019年

Global Granulocyte Macrophage Colony Stimulating Factor Market Professional Survey Report 2019
QYR9NV05606 2019年11月12日 102Pages
※本調査レポートは、顆粒球マクロファージコロニー刺激因子の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、CG-0070、ギムシルマブ、GSK-3196165、...

世界のエリスロポエチン（EPO）薬剤市場規模・現状・予測（2021年-2027年）

Global Erythropoietin (EPO) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4206 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、エリスロポエチン（EPO）薬剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エポエチンアルファ、ダルベポエチンアルファ）、用途別市場規模（病院、ホームケア、専門クリニック、その他）、主要地域別市場規...

世界の腫瘍壊死因子（TNF）阻害薬市場規模・現状・予測（2021年-2027年）

Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6054 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、腫瘍壊死因子（TNF）阻害薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Humira、Enbrel、Remicade、Simponi/Simponi Aria、Cimzia、バイオシミラー）、用途...

世界のがん支持療法薬剤市場規模・現状・予測（2021年-2027年）

Global Cancer Supportive Care Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5643 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、がん支持療法薬剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（G-CSF（顆粒球コロニー刺激因子）、ESA（赤血球生成刺激剤）、制吐剤、ビスフォスフォネート、オピオイド、NSAID）、用途別市場規模...

世界のトランスフォーミング増殖因子ベータ 2市場規模・現状・予測（2021年-2027年）

Global Transforming Growth Factor Beta 2 Market Size, Status and Forecast 2021-2027
QFJ1-6050 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、トランスフォーミング増殖因子ベータ 2の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（XOMA-089、トラベダーセン、ISTH-0047、その他）、用途別市場規模（多形性膠芽腫、開放隅角緑内障、肝線...

世界の凝固第XI因子市場規模・現状・予測（2021年-2027年）

Global Coagulation Factor XI Market Size, Status and Forecast 2021-2027
QFJ1-5665 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、凝固第XI因子の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（MR-1007、IONIS-FXIRx、EP-7041、AB-022、BMS-262084、その他）、用途別市場規模（血栓症、出血＆凝固障...

世界のNT3成長因子受容体市場規模・現状・予測（2021年-2027年）

Global NT 3 Growth Factor Receptor Market Size, Status and Forecast 2021-2027
QFJ1-5898 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、NT3成長因子受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（AZD-7451、ラロトレクチニブ、DS-6051、LM-22B10、その他）、用途別市場規模（乳がん、脳がん、固形がん、結腸がん、...

世界の上皮成長因子受容体（EGFR）阻害剤市場規模・現状・予測（2021年-2027年）

Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, Status and Forecast 2021-2027
QFJ1-5726 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、上皮成長因子受容体（EGFR）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺がん、大腸がん、乳がん、その他）、用途別市場規模（病院、研究所、研究機関、診療所、その他）、主要地域別市場規模（北...

世界の血管内皮増殖因子（VEGF）阻害剤市場規模・現状・予測（2021年-2027年）

Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-6061 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、血管内皮増殖因子（VEGF）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（VEGF-A阻害剤、VEGF-B阻害剤、VEGF-C阻害剤、VEGF-D阻害剤）、用途別市場規模（腫瘍、眼科）、主要地...

世界の掻痒治療薬市場規模・現状・予測（2021年-2027年）

Global Pruritus Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5973 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、掻痒治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（局所、経口、非経口）、用途別市場規模（血液性そう痒症、腫瘍性そう痒症、腎性そう痒症、内分泌性そう痒症、胆汁うっ滞性そう痒症）、主要地域別市場規...

顆粒球マクロファージコロニー刺激因子のグローバル市場調査 2019年 The global Granulocyte Macrophage Colony Stimulating Factor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Granulocyte Macrophage Colony Stimulating Factor volume and value at global level, regiona…
世界の腫瘍壊死因子（TNF）阻害薬市場規模・現状・予測（2021年-2027年） A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory response. TNF is involved in autoimmune and immune-mediated disorders such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, …
世界のがん支持療法薬剤市場規模・現状・予測（2021年-2027年） Supportive drugs are not anticancer drugs. They protect certain cells or organs from the side effects of chemotherapy drugs or radiation therapy. Increasing uptake of biosimilars, rising expenditure on healthcare, and availability of effective treatment methods, including target specific and tailore…
世界のNT3成長因子受容体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global NT 3 Growth Factor Receptor Market The global NT 3 Growth Factor Receptor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
世界の多発性嚢胞腎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Polycystic Kidney Disease Treatment Drugs Market The global Polycystic Kidney Disease Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in anal…